|

"TARGET Study": Safety and Performance of the Cardiovalve TR Replacement System

RECRUITINGN/ASponsored by Cardiovalve Ltd.
Actively Recruiting
PhaseN/A
SponsorCardiovalve Ltd.
Started2022-12-09
Est. completion2026-08-15
Eligibility
Age18 Years – 85 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05486832

Summary

The objective of this study is to evaluate the safety and performance of Cardiovalve TR system

Eligibility

Age: 18 Years – 85 YearsHealthy volunteers accepted
Inclusion Criteria:

* Functional TR ≥3+
* Symptomatic, NYHA Class II-IVa
* Patient approved by the Subject Screening Committee

Exclusion Criteria:

* Cardiac anatomy deemed not suitable for the Cardiovalve TR system
* Hemodynamic instability
* Severe right ventricular failure
* Refractory heart failure requiring advanced intervention

Conditions2

Heart DiseaseTricuspid Regurgitation

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.